Artesunate Induces ROS-Mediated Apoptosis in Doxorubicin-Resistant T Leukemia Cells
2007
Artesunate Induces Apoptosis in Doxorubicin-Resistant T Leukemia Cells
publication
Evidence: moderate
Author Information
Author(s): Efferth Thomas, Giaisi Marco, Merling Annette, Krammer Peter H., Li-Weber Min
Primary Institution: German Cancer Research Center, Heidelberg, Germany
Hypothesis
Can artesunate overcome drug resistance in leukemia cells?
Conclusion
Artesunate can induce apoptosis in Doxorubicin-resistant leukemia cells through a different mechanism than Doxorubicin.
Supporting Evidence
- Artesunate induces apoptosis in leukemic T cells through the mitochondrial pathway.
- The antioxidant N-Acetyle-Cysteine completely blocks ROS generation and inhibits ART-induced apoptosis.
- ART can synergize with Doxorubicin to enhance apoptotic cell death in leukemic T cells.
Takeaway
Artesunate is a medicine that can help kill cancer cells that are resistant to other treatments, like Doxorubicin.
Methodology
The study used various T-cell leukemia lines to test the effects of artesunate on apoptosis and drug resistance.
Limitations
The study primarily focused on in vitro models and may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website